Evidence map›Paper›PMID 32738194›Full record

ArticleMolecular cell2020

Quality Control of ER Membrane Proteins by the RNF185/Membralin Ubiquitin Ligase Complex.

Michael L van de Weijer, Logesvaran Krshnan, Sabrina Liberatori, Elena Navarro Guerrero, Jacob Robson-Tull, Lilli Hahn, Robert Jan Lebbink, Emmanuel J H J Wiertz, Roman Fischer, Daniel Ebner and 1 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Molecular cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Dsc complex and its role in Golgi quality control.Biochemical Society transactions · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Michael L van de WeijerSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
Logesvaran KrshnanSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
Sabrina LiberatoriSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
Elena Navarro GuerreroNuffield Department of Medicine, Target Discovery Institute, University of Oxford, Oxford OX3 7FZ, UK.
Jacob Robson-TullSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
Lilli HahnSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
Robert Jan LebbinkMedical Microbiology, University Medical Center Utrecht, 3584 Utrecht, the Netherlands.
Emmanuel J H J WiertzMedical Microbiology, University Medical Center Utrecht, 3584 Utrecht, the Netherlands.
Roman FischerNuffield Department of Medicine, Target Discovery Institute, University of Oxford, Oxford OX3 7FZ, UK.
Daniel EbnerNuffield Department of Medicine, Target Discovery Institute, University of Oxford, Oxford OX3 7FZ, UK.
Pedro CarvalhoSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK. Electronic address: pedro.carvalho@path.ox.ac.uk.
University of Oxford · GBUniversity Medical Center Utrecht · NL

Funding

Wellcome TrustWellcome Trust 202642/Z/16/Z
6 · The paper itself

Abstract

Misfolded proteins in the endoplasmic reticulum (ER) are degraded by ER-associated degradation (ERAD). Although ERAD components involved in degradation of luminal substrates are well characterized, much less is known about quality control of membrane proteins. Here, we analyzed the degradation pathways of two short-lived ER membrane model proteins in mammalian cells. Using a CRISPR-Cas9 genome-wide library screen, we identified an ERAD branch required for quality control of a subset of membrane proteins. Using biochemical and mass spectrometry approaches, we showed that this ERAD branch is defined by an ER membrane complex consisting of the ubiquitin ligase RNF185, the ubiquitin-like domain containing proteins TMUB1/2 and TMEM259/Membralin, a poorly characterized protein. This complex cooperates with cytosolic ubiquitin ligase UBE3C and p97 ATPase in degrading their membrane substrates. Our data reveal that ERAD branches have remarkable specificity for their membrane substrates, suggesting that multiple, perhaps combinatorial, determinants are involved in substrate selection.

Indexed as

Cell LineCRISPR-Cas SystemsCytochrome P-450 Enzyme SystemEndoplasmic ReticulumHEK293 CellsHeLa CellsHumansMembrane ProteinsMitochondrial ProteinsNerve Tissue ProteinsProtein DomainsProtein FoldingProteolysisSaccharomyces cerevisiae ProteinsSterol 14-DemethylaseUbiquitin-Protein LigasesCYP51A1 protein, humanCytochrome P-450 Enzyme SystemErg11 protein, S cerevisiaeMembrane ProteinsMitochondrial ProteinsNerve Tissue ProteinsRNF185 protein, humanSaccharomyces cerevisiae ProteinsSterol 14-DemethylaseTMEM259 protein, humanUbiquitin-Protein Ligasesendoplasmic reticulumERADER-associated degradationmembralinprotein quality controlRNF185TEB4/MARCH6TMEM259TMUB1/TMUB2UBE3C

Identifiers

PMID32738194
PMCPMC7482433
OpenAlexW3046507432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.